TBPH CIK: 1583107

Theravance Biopharma, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.21
FY22:
−0.19
FY23:
−0.03
FY24:
−0.01
FY25:
0.24
Change from FY21 to FY25
billions USD
FY21:
0.12
FY22:
1.15
FY23:
−0.03
FY24:
0.01
FY25:
−0.11
Change from FY21 to FY25
billions USD
FY21:
0.09
FY22:
−0.76
FY23:
−0.20
FY24:
0.00
FY25:
0.00
billions USD
FY21:
0.01
FY22:
0.21
FY23:
−0.26
FY24:
0.00
FY25:
0.13
(positive)
Change from FY21 to FY25
billions USD
FY21:
−0.21
FY22:
−0.19
FY23:
−0.03
FY24:
−0.01
FY25:
0.24

All amounts in billions USD Data source:SEC EDGAR